{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:38:41Z","timestamp":1790624321563,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metastatic relapse remains the main cause of treatment failure in pediatric osteosarcoma (OS), as conventional imaging often misses minimal residual or low-burden disease. Circulating tumor cells (CTCs) represent a promising non-invasive biomarker for monitoring tumor progression and heterogeneity. We developed an integrated workflow to isolate, enrich, and molecularly characterize CTCs from six pediatric OS patients. Peripheral blood mononuclear cells were enriched using the Parsortix system. CTCs were classified by immunofluorescence using epithelial (EpCAM, CK8\/18\/19) and mesenchymal (Vimentin, TWIST1) markers. Single cells were isolated via DEPArray, followed by whole-genome amplification and low-pass sequencing to assess copy number alterations (CNAs). In one patient, whole-exome sequencing (WES) was performed on bulk CTCs, primary tumor, and metastatic tissue to confirm tumor origin and identify shared somatic mutations. Across the cohort, 908 CTCs were identified, predominantly mesenchymal, with a smaller epithelial subset showing higher genomic complexity and CNA burden. WES confirmed overlapping mutations and CNAs among CTCs, primary, and metastatic tumors. Epithelial CTCs exhibited greater genomic instability than mesenchymal cells. Phenotype correlations with treatment response suggested potential links to histological necrosis. This study provides the first comprehensive phenotypic and genomic characterization of CTCs in pediatric OS, confirming their neoplastic nature and molecular heterogeneity. These findings support CTC-based monitoring as a minimally invasive tool for guiding personalized therapy and improving disease surveillance in high-risk OS patients.<\/jats:p>","DOI":"10.1038\/s41598-026-47094-5","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:35:18Z","timestamp":1775172918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding CTCs in osteosarcoma: the molecular journey from initial tumor to metastasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Alessandro","family":"Di Gangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Ipponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Coccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Aretini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Menicagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Casazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Iantomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Maria","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"47094_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/548151","volume":"2011","author":"SA Savage","year":"2011","unstructured":"Savage, S. A. & Mirabello, L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011, 548151 (2011).","journal-title":"Sarcoma"},{"issue":"3","key":"47094_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","volume":"20","author":"SS Bielack","year":"2002","unstructured":"Bielack, S. S. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J. Clin. Oncol. 20(3), 776\u2013790 (2002).","journal-title":"J. Clin. Oncol."},{"key":"47094_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejca.2022.09.007","volume":"176","author":"SS Bielack","year":"2022","unstructured":"Bielack, S. S. et al. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS). Eur. J. Cancer 176, 50\u201357 (2022).","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"47094_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1302\/0301-620X.102B6.BJJ-2019-1307.R1","volume":"102-B","author":"Y Tsuda","year":"2020","unstructured":"Tsuda, Y. et al. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma. Bone Joint J. 102-B(6), 795\u2013803 (2020).","journal-title":"Bone Joint J."},{"issue":"2","key":"47094_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/annonc\/mdu526","volume":"26","author":"JS Whelan","year":"2015","unstructured":"Whelan, J. S. et al. EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment. Ann. Oncol. 26(2), 407\u2013414 (2015).","journal-title":"Ann. Oncol."},{"issue":"16","key":"47094_CR6","doi-asserted-by":"publisher","first-page":"e99791","DOI":"10.1172\/jci.insight.99791","volume":"3","author":"AC Gross","year":"2018","unstructured":"Gross, A. C. et al. IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis. JCI Insight 3(16), e99791 (2018).","journal-title":"JCI Insight"},{"key":"47094_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.10.011","volume":"343","author":"MF Heymann","year":"2019","unstructured":"Heymann, M. F., L\u00e9zot, F. & Heymann, D. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. Cell. Immunol. 343, 103711 (2019).","journal-title":"Cell. Immunol."},{"issue":"15","key":"47094_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155451","volume":"21","author":"A Mazumdar","year":"2020","unstructured":"Mazumdar, A. et al. Osteosarcoma-derived extracellular vesicles induce lung fibroblast reprogramming. Int. J. Mol. Sci. 21(15), 5451 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"47094_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2012.06.006","volume":"325","author":"B Tu","year":"2012","unstructured":"Tu, B., Du, L., Fan, Q. M., Tang, Z. & Tang, T. T. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Lett. 325(1), 80\u201388 (2012).","journal-title":"Cancer Lett."},{"issue":"12","key":"47094_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210086","volume":"24","author":"R Gaeta","year":"2023","unstructured":"Gaeta, R. et al. Identification of new potential prognostic and predictive markers in high-grade osteosarcoma using whole exome sequencing. Int. J. Mol. Sci. 24(12), 10086 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"47094_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-030-43032-0_9","volume":"1257","author":"DS Shulman","year":"2020","unstructured":"Shulman, D. S. & Crompton, B. D. Using liquid biopsy in the treatment of patient with OS. Adv. Exp. Med. Biol. 1257, 95\u2013105 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"47094_CR12","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1158\/1078-0432.CCR-22-2912","volume":"29","author":"S Udomruk","year":"2023","unstructured":"Udomruk, S. et al. Characterization of cell-free DNA size distribution in osteosarcoma patients. Clin. Cancer Res. 29(11), 2085\u20132094 (2023).","journal-title":"Clin. Cancer Res."},{"key":"47094_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2022.03.002","volume":"168","author":"I Lyskj\u00e6r","year":"2022","unstructured":"Lyskj\u00e6r, I. et al. Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA. Eur. J. Cancer 168, 1\u201311 (2022).","journal-title":"Eur. J. Cancer"},{"key":"47094_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jbo.2018.07.002","volume":"12","author":"A Chalopin","year":"2018","unstructured":"Chalopin, A. et al. Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy. J. Bone Oncol. 12, 83\u201390 (2018).","journal-title":"J. Bone Oncol."},{"issue":"11","key":"47094_CR15","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1158\/1535-7163.MCT-12-0460","volume":"11","author":"A Giordano","year":"2012","unstructured":"Giordano, A. et al. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. Mol. Cancer Ther. 11(11), 2526\u20132534 (2012).","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"47094_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41568-022-00536-4","volume":"23","author":"A Ring","year":"2023","unstructured":"Ring, A., Nguyen-Str\u00e4uli, B. D., Wicki, A. & Aceto, N. Biology, vulnerabilities and clinical applications of circulating tumour cells. Nat. Rev. Cancer 23(2), 95\u2013111 (2023).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"47094_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","volume":"13","author":"S Riethdorf","year":"2007","unstructured":"Riethdorf, S. et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the Cell Search system. Clin. Cancer Res. 13(3), 920\u2013928 (2007).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"47094_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molonc.2015.12.002","volume":"10","author":"KC Andree","year":"2016","unstructured":"Andree, K. C., van Dalum, G. & Terstappen, L. W. M. M. Challenges in circulating tumor cell detection by the CellSearch system. Mol. Oncol. 10(3), 395\u2013407 (2016).","journal-title":"Mol. Oncol."},{"key":"47094_CR19","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/CMAR.S176515","volume":"10","author":"ZJ Wu","year":"2018","unstructured":"Wu, Z. J., Tan, J. C., Qin, X., Liu, B. & Yuan, Z. C. Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery. Cancer Manag. Res. 10, 3333\u20133339 (2018).","journal-title":"Cancer Manag. Res."},{"issue":"17","key":"47094_CR20","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1158\/0008-5472.CAN-17-0032","volume":"77","author":"G Sannino","year":"2017","unstructured":"Sannino, G., Marchetto, A., Kirchner, T. & Gr\u00fcnewald, T. G. P. Epithelial-to-mesenchymal and mesenchymal-to-epithelial transition in mesenchymal tumors: A paradox in sarcomas?. Cancer Res. 77(17), 4556\u20134561 (2017).","journal-title":"Cancer Res."},{"issue":"2","key":"47094_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020360","volume":"14","author":"GA Odri","year":"2022","unstructured":"Odri, G. A., Tchicaya-Bouanga, J., Yoon, D. J. Y. & Modrowski, D. Metastatic progression of osteosarcomas: A review of current knowledge of environmental versus oncogenic drivers. Cancers (Basel) 14(2), 360 (2022).","journal-title":"Cancers (Basel)"},{"key":"47094_CR22","volume":"7","author":"RJ Young","year":"2024","unstructured":"Young, R. J., Chowdry, J. E., Cochonneau, D. & Heymann, D. CIRCUS: CIRCUlating tumour cells in soft tissue sarcoma\u2014A short report. Cancer Drug Resist. 7, 51 (2024).","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"47094_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/iub.573","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap, A. P. The monocarboxylate transporter family\u2013Structure and functional characterization. IUBMB Life 64(1), 1\u20139 (2012).","journal-title":"IUBMB Life"},{"key":"47094_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13018-023-03623-w","volume":"18","author":"G Sheng","year":"2023","unstructured":"Sheng, G., Gao, Y., Wu, H., Liu, Y. & Yang, Y. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis. J. Orthop. Surg. Res. 18, 131 (2023).","journal-title":"J. Orthop. Surg. Res."},{"issue":"3","key":"47094_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1083\/jcb.123.3.561","volume":"123","author":"LM Traub","year":"1993","unstructured":"Traub, L. M., Ostrom, J. A. & Kornfeld, S. Biochemical dissection of AP-1 recruitment onto Golgi membranes. J. Cell Biol. 123(3), 561\u2013573 (1993).","journal-title":"J. Cell Biol."},{"issue":"10","key":"47094_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrm2774","volume":"10","author":"N Hirokawa","year":"2009","unstructured":"Hirokawa, N., Noda, Y., Tanaka, Y. & Niwa, S. Kinesin superfamily motor proteins and intracellular transport. Nat. Rev. Mol. Cell Biol. 10(10), 682\u2013696 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5237","key":"47094_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.270.5237.819","volume":"270","author":"S Noguchi","year":"1995","unstructured":"Noguchi, S. et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270(5237), 819\u2013822 (1995).","journal-title":"Science"},{"issue":"6","key":"47094_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/CCO.0b013e32833de186","volume":"22","author":"C Criscitiello","year":"2010","unstructured":"Criscitiello, C., Sotiriou, C. & Ignatiadis, M. Circulating tumor cells and emerging blood biomarkers in breast cancer. Curr. Opin. Oncol. 22(6), 552 (2010).","journal-title":"Curr. Opin. Oncol."},{"issue":"2","key":"47094_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrurol.2016.224","volume":"14","author":"MA Gorin","year":"2017","unstructured":"Gorin, M. A. et al. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer. Nat. Rev. Urol. 14(2), 90\u201397 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"47094_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100357","volume":"28","author":"HO Fasanya","year":"2021","unstructured":"Fasanya, H. O., Dopico, P. J., Yeager, Z., Fan, Z. H. & Siemann, D. W. Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices. J. Bone Oncol. 28, 100357 (2021).","journal-title":"J. Bone Oncol."},{"issue":"1","key":"47094_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00600-w","volume":"11","author":"X Yu","year":"2021","unstructured":"Yu, X., Yustein, J. T. & Xu, J. Research models and mesenchymal\/epithelial plasticity of osteosarcoma. Cell Biosci. 11(1), 94 (2021).","journal-title":"Cell Biosci."},{"issue":"5","key":"47094_CR32","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00432-022-04202-y","volume":"149","author":"E Acheampong","year":"2023","unstructured":"Acheampong, E. et al. Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients. J. Cancer Res. Clin. Oncol. 149(5), 1941\u20131950 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"47094_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1586\/14737159.2016.1123095","volume":"16","author":"NH Stoecklein","year":"2016","unstructured":"Stoecklein, N. H., Fischer, J. C., Niederacher, D. & Terstappen, L. W. M. M. Challenges for CTC-based liquid biopsies: Low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev. Mol. Diagn. 16(2), 147\u2013164 (2016).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"47094_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111068","volume":"133","author":"Z Chen","year":"2021","unstructured":"Chen, Z., Fang, Z. & Ma, J. Regulatory mechanisms and clinical significance of vimentin in breast cancer. Biomed. Pharmacother. 133, 111068 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"47094_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10763-7","volume":"7","author":"PP Lin","year":"2017","unstructured":"Lin, P. P., Gires, O., Wang, D. D., Li, L. & Wang, H. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells. Sci. Rep. 7(1), 9789 (2017).","journal-title":"Sci. Rep."},{"key":"47094_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.819357","volume":"13","author":"S Dai","year":"2023","unstructured":"Dai, S. et al. Association of circulating tumor cells and IMP3 expression with metastasis of osteosarcoma. Front. Oncol. 13, 819357 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"47094_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird, H. C. et al. Osteosarcoma. Nat. Rev. Dis. Primers 8(1), 77 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"47094_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu, W. & Kang, Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev. Cell 49(3), 361\u2013374 (2019).","journal-title":"Dev. Cell"},{"issue":"22","key":"47094_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225482","volume":"15","author":"Y Ito","year":"2023","unstructured":"Ito, Y. et al. Mobilization of circulating tumor cells after short- and long-term FOLFIRINOX and GEM\/nab-PTX chemotherapy in xenograft mouse models of human pancreatic cancer. Cancers (Basel) 15(22), 5482 (2023).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"47094_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06092-3","volume":"23","author":"ML Espejo-Cruz","year":"2025","unstructured":"Espejo-Cruz, M. L. et al. Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma. J. Transl. Med. 23(1), 139 (2025).","journal-title":"J. Transl. Med."},{"issue":"6","key":"47094_CR41","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E","volume":"49","author":"G Rosen","year":"1982","unstructured":"Rosen, G. et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49(6), 1221\u20131230 (1982).","journal-title":"Cancer"},{"key":"47094_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1200\/CCI.19.00132","volume":"4","author":"KA Pagel","year":"2020","unstructured":"Pagel, K. A. et al. Integrated informatics analysis of cancer-related variants. JCO Clin. Cancer Inform. 4, 310\u2013317 (2020).","journal-title":"JCO Clin. Cancer Inform."},{"issue":"21","key":"47094_CR43","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson, J. T., Thorvaldsd\u00f3ttir, H., Wenger, A. M., Zehir, A. & Mesirov, J. P. Variant review with the Integrative Genomics Viewer. Cancer Res. 77(21), e31\u2013e34 (2017).","journal-title":"Cancer Res."},{"key":"47094_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50267","volume":"9","author":"S Franch-Exp\u00f3sito","year":"2020","unstructured":"Franch-Exp\u00f3sito, S. et al. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications. Elife 9, e50267 (2020).","journal-title":"Elife"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47094-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:26:06Z","timestamp":1781645166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47094"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47094-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15838"}}